Nanoscale Horiz., 2023, 8,746-758
DOI: 10.1039/D2NH00570K, Communication
DOI: 10.1039/D2NH00570K, Communication
Liwen Yuan, Yanpin Chen, Longfeng Ke, Quan Zhou, Jiayou Chen, Min Fan, Alain Wuethrich, Matt Trau, Jing Wang
A nanostrategy that combines bright core–shell probes, a nanomixing chip, and machine learning was proposed to evaluate the clinical performance of plasma EV phenotypes in differentiating early-stage lung cancer and benign lung diseases.
The content of this RSS Feed (c) The Royal Society of Chemistry
A nanostrategy that combines bright core–shell probes, a nanomixing chip, and machine learning was proposed to evaluate the clinical performance of plasma EV phenotypes in differentiating early-stage lung cancer and benign lung diseases.
The content of this RSS Feed (c) The Royal Society of Chemistry